Matthew J. Crowley

Part of Dassault Systèmes SA, Afferent Systems, Inc. develops software for the healthcare industry. The company is based in San Francisco, CA. Afferent Systems was acquired by MDL Information Systems, Inc., part of Dassault Systèmes SA from October 02, 2007 on July 19, 2001.

Galen Nanosystems provides nanomechanical resonator technology solutions. The company is headquartered in Boston, MA.

Sandburst Corp. develops and markets fables semiconductor chipsets to the communications and data networking markets. Sandburst Ethernet foundation architecture provides its system vendor clients with a complete packet switching data path for enterprise and metropolitan area networks. Sandburst was founded by Arvind in 2000 and is headquartered in Andover, MA

The Boston University Office of Technology Development invests through the Boston University Technology Fund. The Fund provides venture capital and access to Boston University's scientific and technical resources for promising companies

Elixir Pharmaceuticals, Inc. operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases such as diabetes and obesity. The company was founded by Leonard Guarente, Cynthia J. Kenyon, Cindy Bayley, Louis Kunkel, Annibale Puca, and Thomas Perls in 1999 and is headquartered in Cambridge, MA.

Microchips Biotech, Inc. develops drug delivery systems and bio sensing devices. Its technologies are designed to transform electromechanical medical devices into highly tuned biochemical sensing and therapy systems. The company was founded by Terrance G. McGuire, Michael J. Cima, John T. Santini, Jr. and Robert S. Langer, Jr. in 1999 and is headquartered in Lexington, MA.

SelectX Pharmaceuticals, Inc. engages in the discovery and development of aminoglycoside therapeutics for unmet medical needs. Its advanced program, development candidate SXP2523, is a next generation aminoglycoside antibiotic for drug resistant gram-negative hospital-acquired infections (HAIs); SXP2523 possesses broad spectrum coverage with potency against Pseudomonas, Klebsiella, Acinetobacter, E. coli, and Staphylococcus. The company was founded by Michael G. Chaparian and Charles R. Cantor in 2002 and is headquartered in Boston, MA.

StarGen, Inc. is a semi-conductor company that develops communications chips. They offer serial switched interconnect solutions for compute and communication equipments. The company was founded in 1999 and is headquartered in Marlborough, MA.